| Roche inaugurates new R&D building in Basel |
| 25.11.11 09:35 | |
|
Investment of roughly CHF 250 million in centre for technical research and development Today Roche announced the opening of a new R&D building in Basel. The facility, which represents an investment of CHF 250 million, will be used to investigate and develop pharmaceutical formulations for new active ingredients, as well as manufacture supplies for global clinical trials. "Finding the safest and most efficient formulation for an active ingredient is a key part of the drug development process." said Roche Group CEO Severin Schwan. “Functions from the entire pharmaceutical value-chain are located in Basel. This investment further strengthens the role of Basel headquarters and as a global centre for research and development. “ "Basel is a global centre of excellence for innovative formulation processes. By expanding our capacity in this field, we will be able to respond even more effectively to patients' needs and make medication easier to use“, added Matthias M. Baltisberger, Head of the Basel Site. „This will be the first time in Roche's history that employees in technical research and development will actually be sharing the same working area. By working together in close proximity they will be able to collaborate even closer on this pivotal aspect of drug development." |
| < Prev | Next > |
|---|